Argent Capital Management LLC Pfizer Inc Transaction History

Argent Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $1.14 Million - $1.29 Million	-34,621 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $18.2 Million - $23.6 Million	-560,059 Reduced 94.18%	34,621 $1.24 Million
Q2 2019 Aug 15, 2019	SELL	$36.98 - $41.52 $1.09 Million - $1.22 Million	-29,481 Reduced 4.72%	594,680 $25.8 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $333,900 - $366,844	-8,904 Reduced 1.41%	624,161 $26.5 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $2.01 Million - $2.29 Million	52,189 Added 8.98%	633,065 $27.6 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $1.75 Million - $2.12 Million	-50,755 Reduced 8.04%	580,876 $25.6 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $540,707 - $576,448	16,395 Added 2.66%	631,631 $22.9 Million
Q1 2018 May 03, 2018	SELL	$31.91 - $37.02 $482,128 - $559,335	-15,109 Reduced 2.4%	615,236 $21.8 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $9,312 - $9,881	-280 Reduced 0.04%	630,345 $23.3 Million
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $2.64 Million - $2.91 Million	85,157 Added 15.61%	630,625 $22.5 Million
Q2 2017 Aug 15, 2017	BUY	N/A	545,468	545,468 $18.3 Million

3,244

3.65B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Argent Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Argent Capital Management LLC with notifications on news.